Signal / reference desk
Peptide library
Follow a claim back to its sources. Open an entry, check the scope of its reference fields, and use the reading questions to inspect the evidence.
Topic and evidence labels organize reading; they are not recommendations. Approval is specific to a product, route, and use.
Browse the entriesReading map
Choose a topic
An abstract guide to the index.
Topic labels help you navigate. They do not describe an effect on the body.
The reference index
11 of 11 entries
Semaglutide
Wegovy
- Status
- Approved product
- Evidence
- Randomized evidence
Tirzepatide
Zepbound
- Status
- Approved product
- Evidence
- Randomized evidence
Liraglutide
Saxenda
- Status
- Approved product
- Evidence
- Randomized evidence
Dulaglutide
Trulicity
- Status
- Approved product
- Evidence
- Randomized evidence
Retatrutide
LY3437943
- Status
- Investigational
- Evidence
- Randomized evidence
Cagrilintide
- Status
- Investigational
- Evidence
- Randomized evidence
Tesamorelin
Egrifta WR
- Status
- Approved product
- Evidence
- Randomized evidence
Bremelanotide
Vyleesi
- Status
- Approved product
- Evidence
- Randomized evidence
Copper tripeptide-1
GHK-Cu
- Status
- Topical cosmetic
- Evidence
- Cosmetic-use evidence
BPC-157
- Status
- Not FDA-approved
- Evidence
- Early human evidence
Ipamorelin
Ipamorelin acetate
- Status
- Not FDA-approved
- Evidence
- Randomized evidence
No entries match this combination.
Try a shorter name, choose another topic, or clear the filters to return to the full index.
Educational reference material. No clinician review is claimed. This library does not provide personal medical advice.